These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 21704908)

  • 21. Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt.
    Uhrbom L; Dai C; Celestino JC; Rosenblum MK; Fuller GN; Holland EC
    Cancer Res; 2002 Oct; 62(19):5551-8. PubMed ID: 12359767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Receptor tyrosine kinase genes amplified in glioblastoma exhibit a mutual exclusivity in variable proportions reflective of individual tumor heterogeneity.
    Little SE; Popov S; Jury A; Bax DA; Doey L; Al-Sarraj S; Jurgensmeier JM; Jones C
    Cancer Res; 2012 Apr; 72(7):1614-20. PubMed ID: 22311673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of interleukin-13 receptor alpha2 in glioblastoma multiforme: implications for targeted therapies.
    Jarboe JS; Johnson KR; Choi Y; Lonser RR; Park JK
    Cancer Res; 2007 Sep; 67(17):7983-6. PubMed ID: 17804706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HSP27 protects against ferroptosis of glioblastoma cells.
    Yuan F; Sun Q; Zhang S; Ye L; Xu Y; Xu Z; Liu B; Zhang S; Chen Q
    Hum Cell; 2022 Jan; 35(1):238-249. PubMed ID: 34791597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The emerging role of MMP14 in brain tumorigenesis and future therapeutics.
    Ulasov I; Yi R; Guo D; Sarvaiya P; Cobbs C
    Biochim Biophys Acta; 2014 Aug; 1846(1):113-20. PubMed ID: 24657728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multigene profiling to identify alternative treatment options for glioblastoma: a pilot study.
    Tabone T; Abuhusain HJ; Nowak AK; ; Erber WN; McDonald KL
    J Clin Pathol; 2014 Jul; 67(7):550-5. PubMed ID: 24695838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Epigenetic regulation in glioblastomas].
    Quillien V
    Ann Pathol; 2009 Nov; 29 Spec No 1():S34-6. PubMed ID: 19887247
    [No Abstract]   [Full Text] [Related]  

  • 28. Surface-immobilized aptamers for cancer cell isolation and microscopic cytology.
    Wan Y; Kim YT; Li N; Cho SK; Bachoo R; Ellington AD; Iqbal SM
    Cancer Res; 2010 Nov; 70(22):9371-80. PubMed ID: 21062984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of Myc and let-7a in glioblastoma, glucose metabolism and response to therapy.
    Wang G; Wang J; Zhao H; Wang J; Tony To SS
    Arch Biochem Biophys; 2015 Aug; 580():84-92. PubMed ID: 26151775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. KIAA1797/FOCAD encodes a novel focal adhesion protein with tumour suppressor function in gliomas.
    Brockschmidt A; Trost D; Peterziel H; Zimmermann K; Ehrler M; Grassmann H; Pfenning PN; Waha A; Wohlleber D; Brockschmidt FF; Jugold M; Hoischen A; Kalla C; Waha A; Seifert G; Knolle PA; Latz E; Hans VH; Wick W; Pfeifer A; Angel P; Weber RG
    Brain; 2012 Apr; 135(Pt 4):1027-41. PubMed ID: 22427331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peptide micelle-mediated delivery of tissue-specific suicide gene and combined therapy with avastin in a glioblastoma model.
    Oh B; Han J; Choi E; Tan X; Lee M
    J Pharm Sci; 2015 Apr; 104(4):1461-9. PubMed ID: 25631673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of homozygous deletion of the p16 gene and correlation with survival in patients with glioblastoma multiforme.
    Kamiryo T; Tada K; Shiraishi S; Shinojima N; Nakamura H; Kochi M; Kuratsu J; Saya H; Ushio Y
    J Neurosurg; 2002 May; 96(5):815-22. PubMed ID: 12005388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular and cellular heterogeneity: the hallmark of glioblastoma.
    Aum DJ; Kim DH; Beaumont TL; Leuthardt EC; Dunn GP; Kim AH
    Neurosurg Focus; 2014 Dec; 37(6):E11. PubMed ID: 25434380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The infrequent simultaneous genetic alterations in glioblastoma multiforme (LOH 10, 17, 19q, TP53 mutation and EGFR amplification) with short clinical course.
    Jesionek-Kupnicka D; Kulczycka D; Rieske P; Szybka M; Jabłońska J; Potemski P; Kolasa P; Liberski PP; Kordek R
    Pol J Pathol; 2007; 58(2):79-85. PubMed ID: 17715673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imaging genomic mapping in glioblastoma.
    Zinn PO; Colen RR
    Neurosurgery; 2013 Aug; 60 Suppl 1():126-30. PubMed ID: 23839364
    [No Abstract]   [Full Text] [Related]  

  • 36. Therapeutic strategies for inhibiting invasion in glioblastoma.
    Drappatz J; Norden AD; Wen PY
    Expert Rev Neurother; 2009 Apr; 9(4):519-34. PubMed ID: 19344303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibrinogen-like protein 2: a potential molecular target for glioblastoma treatment.
    Patel R; Traylor JI; Latha K; Heimberger AB; Li S; Rao G
    Expert Opin Ther Targets; 2019 Aug; 23(8):647-649. PubMed ID: 31167575
    [No Abstract]   [Full Text] [Related]  

  • 38. Incidence of the main genetic markers in glioblastoma multiforme is independent of tumor topology.
    Necesalová E; Vranová V; Kuglík P; Cejpek P; Jarosová M; Pesáková M; Relichová J; Veselská R
    Neoplasma; 2007; 54(3):212-8. PubMed ID: 17447852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Basic and Translational Advances in Glioblastoma.
    Piccirillo SGM; Alonso MM; Pasqualetti F
    Biomed Res Int; 2018; 2018():1820345. PubMed ID: 29780818
    [No Abstract]   [Full Text] [Related]  

  • 40. Glia/ischemia tissue dual specific gene expression vector for glioblastoma gene therapy.
    Kim HA; Park JH; Cho SH; Lee J; Lee M
    J Control Release; 2011 Nov; 152 Suppl 1():e146-8. PubMed ID: 22195812
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.